Click for best price
Hypoactive Sexual Desire Disorder Medication Market Size, Share 2024
The global Hypoactive Sexual Desire Disorder Medication market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Hypoactive Sexual Desire Disorder Medication include Sprout Pharmaceuticals, Inc., Covis Pharma GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., Zydus Group, Sun Pharmaceutical Industries Ltd, Abbvie,Inc and EndoCeutics, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hypoactive Sexual Desire Disorder Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hypoactive Sexual Desire Disorder Medication. This report contains market size and forecasts of Hypoactive Sexual Desire Disorder Medication in global, including the following market information:
Global Hypoactive Sexual Desire Disorder Medication Market Revenue, 2020-2024, 2025-2030, ($ millions)
Global Hypoactive Sexual Desire Disorder Medication Market Sales, 2020-2024, 2025-2030, (K Units)
Global top five Hypoactive Sexual Desire Disorder Medication companies in 2023 (%)
We surveyed the Hypoactive Sexual Desire Disorder Medication manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hypoactive Sexual Desire Disorder Medication Market, by Type, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Hypoactive Sexual Desire Disorder Medication Market Segment Percentages, by Type, 2023 (%)
Oral
Parenteral
Others
Global Hypoactive Sexual Desire Disorder Medication Market, by Application, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Hypoactive Sexual Desire Disorder Medication Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Hypoactive Sexual Desire Disorder Medication Market, By Region and Country, 2020-2024, 2025-2030 ($ Millions) & (K Units)
Global Hypoactive Sexual Desire Disorder Medication Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hypoactive Sexual Desire Disorder Medication revenues in global market, 2020-2024 (Estimated), ($ millions)
Key companies Hypoactive Sexual Desire Disorder Medication revenues share in global market, 2023 (%)
Key companies Hypoactive Sexual Desire Disorder Medication sales in global market, 2020-2024 (Estimated), (K Units)
Key companies Hypoactive Sexual Desire Disorder Medication sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sprout Pharmaceuticals, Inc.
Covis Pharma GmbH
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC.
Zydus Group
Sun Pharmaceutical Industries Ltd
Abbvie,Inc
EndoCeutics, Inc.
S1 BIOPHARMA INC.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hypoactive Sexual Desire Disorder Medication, market overview.
Chapter 2: Global Hypoactive Sexual Desire Disorder Medication market size in revenue and volume.
Chapter 3: Detailed analysis of Hypoactive Sexual Desire Disorder Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hypoactive Sexual Desire Disorder Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hypoactive Sexual Desire Disorder Medication capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hypoactive Sexual Desire Disorder Medication Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hypoactive Sexual Desire Disorder Medication Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hypoactive Sexual Desire Disorder Medication Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hypoactive Sexual Desire Disorder Medication Overall Market Size
2.1 Global Hypoactive Sexual Desire Disorder Medication Market Size: 2023 VS 2030
2.2 Global Hypoactive Sexual Desire Disorder Medication Revenue, Prospects & Forecasts: 2020-2030
2.3 Global Hypoactive Sexual Desire Disorder Medication Sales: 2020-2030
3 Company Landscape
3.1 Top Hypoactive Sexual Desire Disorder Medication Players in Global Market
3.2 Top Global Hypoactive Sexual Desire Disorder Medication Companies Ranked by Revenue
3.3 Global Hypoactive Sexual Desire Disorder Medication Revenue by Companies
3.4 Global Hypoactive Sexual Desire Disorder Medication Sales by Companies
3.5 Global Hypoactive Sexual Desire Disorder Medication Price by Manufacturer (2020-2024)
3.6 Top 3 and Top 5 Hypoactive Sexual Desire Disorder Medication Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Hypoactive Sexual Desire Disorder Medication Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder Medication Players in Global Market
3.8.1 List of Global Tier 1 Hypoactive Sexual Desire Disorder Medication Companies
3.8.2 List of Global Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder Medication Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hypoactive Sexual Desire Disorder Medication Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.1.4 Others
4.2 By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts
4.2.1 By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2024
4.2.2 By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2025-2030
4.2.3 By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
4.3 By Type - Global Hypoactive Sexual Desire Disorder Medication Sales & Forecasts
4.3.1 By Type - Global Hypoactive Sexual Desire Disorder Medication Sales, 2020-2024
4.3.2 By Type - Global Hypoactive Sexual Desire Disorder Medication Sales, 2025-2030
4.3.3 By Type - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
4.4 By Type - Global Hypoactive Sexual Desire Disorder Medication Price (Manufacturers Selling Prices), 2020-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hypoactive Sexual Desire Disorder Medication Market Size, 2023 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts
5.2.1 By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2024
5.2.2 By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2025-2030
5.2.3 By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
5.3 By Application - Global Hypoactive Sexual Desire Disorder Medication Sales & Forecasts
5.3.1 By Application - Global Hypoactive Sexual Desire Disorder Medication Sales, 2020-2024
5.3.2 By Application - Global Hypoactive Sexual Desire Disorder Medication Sales, 2025-2030
5.3.3 By Application - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
5.4 By Application - Global Hypoactive Sexual Desire Disorder Medication Price (Manufacturers Selling Prices), 2020-2030
6 Sights by Region
6.1 By Region - Global Hypoactive Sexual Desire Disorder Medication Market Size, 2023 & 2030
6.2 By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue & Forecasts
6.2.1 By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2024
6.2.2 By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue, 2025-2030
6.2.3 By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
6.3 By Region - Global Hypoactive Sexual Desire Disorder Medication Sales & Forecasts
6.3.1 By Region - Global Hypoactive Sexual Desire Disorder Medication Sales, 2020-2024
6.3.2 By Region - Global Hypoactive Sexual Desire Disorder Medication Sales, 2025-2030
6.3.3 By Region - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
6.4 North America
6.4.1 By Country - North America Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030
6.4.2 By Country - North America Hypoactive Sexual Desire Disorder Medication Sales, 2020-2030
6.4.3 US Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.4.4 Canada Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.4.5 Mexico Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5 Europe
6.5.1 By Country - Europe Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030
6.5.2 By Country - Europe Hypoactive Sexual Desire Disorder Medication Sales, 2020-2030
6.5.3 Germany Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.4 France Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.5 U.K. Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.6 Italy Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.7 Russia Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.8 Nordic Countries Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.5.9 Benelux Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.6 Asia
6.6.1 By Region - Asia Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030
6.6.2 By Region - Asia Hypoactive Sexual Desire Disorder Medication Sales, 2020-2030
6.6.3 China Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.6.4 Japan Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.6.5 South Korea Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.6.6 Southeast Asia Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.6.7 India Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.7 South America
6.7.1 By Country - South America Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030
6.7.2 By Country - South America Hypoactive Sexual Desire Disorder Medication Sales, 2020-2030
6.7.3 Brazil Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.7.4 Argentina Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030
6.8.2 By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales, 2020-2030
6.8.3 Turkey Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.8.4 Israel Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.8.5 Saudi Arabia Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
6.8.6 UAE Hypoactive Sexual Desire Disorder Medication Market Size, 2020-2030
7 Manufacturers & Brands Profiles
7.1 Sprout Pharmaceuticals, Inc.
7.1.1 Sprout Pharmaceuticals, Inc. Company Summary
7.1.2 Sprout Pharmaceuticals, Inc. Business Overview
7.1.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.1.4 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.1.5 Sprout Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Covis Pharma GmbH
7.2.1 Covis Pharma GmbH Company Summary
7.2.2 Covis Pharma GmbH Business Overview
7.2.3 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.2.4 Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.2.5 Covis Pharma GmbH Key News & Latest Developments
7.3 Mylan N.V.
7.3.1 Mylan N.V. Company Summary
7.3.2 Mylan N.V. Business Overview
7.3.3 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.3.4 Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.3.5 Mylan N.V. Key News & Latest Developments
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.4.3 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.4.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.5 Amneal Pharmaceuticals LLC.
7.5.1 Amneal Pharmaceuticals LLC. Company Summary
7.5.2 Amneal Pharmaceuticals LLC. Business Overview
7.5.3 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.5.4 Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.5.5 Amneal Pharmaceuticals LLC. Key News & Latest Developments
7.6 Zydus Group
7.6.1 Zydus Group Company Summary
7.6.2 Zydus Group Business Overview
7.6.3 Zydus Group Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.6.4 Zydus Group Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.6.5 Zydus Group Key News & Latest Developments
7.7 Sun Pharmaceutical Industries Ltd
7.7.1 Sun Pharmaceutical Industries Ltd Company Summary
7.7.2 Sun Pharmaceutical Industries Ltd Business Overview
7.7.3 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.7.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Abbvie,Inc
7.8.1 Abbvie,Inc Company Summary
7.8.2 Abbvie,Inc Business Overview
7.8.3 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.8.4 Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.8.5 Abbvie,Inc Key News & Latest Developments
7.9 EndoCeutics, Inc.
7.9.1 EndoCeutics, Inc. Company Summary
7.9.2 EndoCeutics, Inc. Business Overview
7.9.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.9.4 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.9.5 EndoCeutics, Inc. Key News & Latest Developments
7.10 S1 BIOPHARMA INC.
7.10.1 S1 BIOPHARMA INC. Company Summary
7.10.2 S1 BIOPHARMA INC. Business Overview
7.10.3 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Major Product Offerings
7.10.4 S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales and Revenue in Global (2020-2024)
7.10.5 S1 BIOPHARMA INC. Key News & Latest Developments
8 Global Hypoactive Sexual Desire Disorder Medication Production Capacity, Analysis
8.1 Global Hypoactive Sexual Desire Disorder Medication Production Capacity, 2020-2030
8.2 Hypoactive Sexual Desire Disorder Medication Production Capacity of Key Manufacturers in Global Market
8.3 Global Hypoactive Sexual Desire Disorder Medication Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hypoactive Sexual Desire Disorder Medication Supply Chain Analysis
10.1 Hypoactive Sexual Desire Disorder Medication Industry Value Chain
10.2 Hypoactive Sexual Desire Disorder Medication Upstream Market
10.3 Hypoactive Sexual Desire Disorder Medication Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hypoactive Sexual Desire Disorder Medication Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hypoactive Sexual Desire Disorder Medication in Global Market
Table 2. Top Hypoactive Sexual Desire Disorder Medication Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Hypoactive Sexual Desire Disorder Medication Revenue by Companies, (US$, Mn), 2020-2024
Table 4. Global Hypoactive Sexual Desire Disorder Medication Revenue Share by Companies, 2020-2024
Table 5. Global Hypoactive Sexual Desire Disorder Medication Sales by Companies, (K Units), 2020-2024
Table 6. Global Hypoactive Sexual Desire Disorder Medication Sales Share by Companies, 2020-2024
Table 7. Key Manufacturers Hypoactive Sexual Desire Disorder Medication Price (2020-2024) & (US$/Unit)
Table 8. Global Manufacturers Hypoactive Sexual Desire Disorder Medication Product Type
Table 9. List of Global Tier 1 Hypoactive Sexual Desire Disorder Medication Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypoactive Sexual Desire Disorder Medication Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2020-2024
Table 13. By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2020-2024
Table 15. By Type - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2025-2030
Table 16. By Application ? Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2020-2024
Table 18. By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2020-2024
Table 20. By Application - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2025-2030
Table 21. By Region ? Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2020-2024
Table 23. By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2020-2024
Table 25. By Region - Global Hypoactive Sexual Desire Disorder Medication Sales (K Units), 2025-2030
Table 26. By Country - North America Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2024
Table 27. By Country - North America Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2020-2024
Table 29. By Country - North America Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2025-2030
Table 30. By Country - Europe Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2024
Table 31. By Country - Europe Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2020-2024
Table 33. By Country - Europe Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2025-2030
Table 34. By Region - Asia Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2024
Table 35. By Region - Asia Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2020-2024
Table 37. By Region - Asia Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2025-2030
Table 38. By Country - South America Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2024
Table 39. By Country - South America Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2020-2024
Table 41. By Country - South America Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2024
Table 43. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2020-2024
Table 45. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales, (K Units), 2025-2030
Table 46. Sprout Pharmaceuticals, Inc. Company Summary
Table 47. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 48. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 49. Sprout Pharmaceuticals, Inc. Key News & Latest Developments
Table 50. Covis Pharma GmbH Company Summary
Table 51. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 52. Covis Pharma GmbH Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 53. Covis Pharma GmbH Key News & Latest Developments
Table 54. Mylan N.V. Company Summary
Table 55. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 56. Mylan N.V. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 57. Mylan N.V. Key News & Latest Developments
Table 58. Teva Pharmaceutical Industries Ltd. Company Summary
Table 59. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 60. Teva Pharmaceutical Industries Ltd. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 61. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 62. Amneal Pharmaceuticals LLC. Company Summary
Table 63. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 64. Amneal Pharmaceuticals LLC. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 65. Amneal Pharmaceuticals LLC. Key News & Latest Developments
Table 66. Zydus Group Company Summary
Table 67. Zydus Group Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 68. Zydus Group Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 69. Zydus Group Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Ltd Company Summary
Table 71. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 72. Sun Pharmaceutical Industries Ltd Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 73. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 74. Abbvie,Inc Company Summary
Table 75. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 76. Abbvie,Inc Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 77. Abbvie,Inc Key News & Latest Developments
Table 78. EndoCeutics, Inc. Company Summary
Table 79. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 80. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 81. EndoCeutics, Inc. Key News & Latest Developments
Table 82. S1 BIOPHARMA INC. Company Summary
Table 83. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Product Offerings
Table 84. S1 BIOPHARMA INC. Hypoactive Sexual Desire Disorder Medication Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2020-2024)
Table 85. S1 BIOPHARMA INC. Key News & Latest Developments
Table 86. Hypoactive Sexual Desire Disorder Medication Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 87. Global Hypoactive Sexual Desire Disorder Medication Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global Hypoactive Sexual Desire Disorder Medication Production by Region, 2020-2024 (K Units)
Table 89. Global Hypoactive Sexual Desire Disorder Medication Production by Region, 2025-2030 (K Units)
Table 90. Hypoactive Sexual Desire Disorder Medication Market Opportunities & Trends in Global Market
Table 91. Hypoactive Sexual Desire Disorder Medication Market Drivers in Global Market
Table 92. Hypoactive Sexual Desire Disorder Medication Market Restraints in Global Market
Table 93. Hypoactive Sexual Desire Disorder Medication Raw Materials
Table 94. Hypoactive Sexual Desire Disorder Medication Raw Materials Suppliers in Global Market
Table 95. Typical Hypoactive Sexual Desire Disorder Medication Downstream
Table 96. Hypoactive Sexual Desire Disorder Medication Downstream Clients in Global Market
Table 97. Hypoactive Sexual Desire Disorder Medication Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hypoactive Sexual Desire Disorder Medication Segment by Type in 2023
Figure 2. Hypoactive Sexual Desire Disorder Medication Segment by Application in 2023
Figure 3. Global Hypoactive Sexual Desire Disorder Medication Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hypoactive Sexual Desire Disorder Medication Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hypoactive Sexual Desire Disorder Medication Revenue, 2020-2030 (US$, Mn)
Figure 7. Hypoactive Sexual Desire Disorder Medication Sales in Global Market: 2020-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hypoactive Sexual Desire Disorder Medication Revenue in 2023
Figure 9. By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 11. By Type - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 12. By Type - Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit), 2020-2030
Figure 13. By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 15. By Application - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 16. By Application - Global Hypoactive Sexual Desire Disorder Medication Price (US$/Unit), 2020-2030
Figure 17. By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020 VS 2023 VS 2030
Figure 19. By Region - Global Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 20. By Region - Global Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 21. By Country - North America Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 22. By Country - North America Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 23. US Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 24. Canada Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 25. Mexico Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 26. By Country - Europe Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 27. By Country - Europe Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 28. Germany Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 29. France Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 30. U.K. Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 31. Italy Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 32. Russia Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 33. Nordic Countries Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 34. Benelux Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 35. By Region - Asia Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 36. By Region - Asia Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 37. China Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 38. Japan Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 39. South Korea Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 40. Southeast Asia Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 41. India Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 42. By Country - South America Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 43. By Country - South America Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 44. Brazil Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 45. Argentina Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 46. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Revenue Market Share, 2020-2030
Figure 47. By Country - Middle East & Africa Hypoactive Sexual Desire Disorder Medication Sales Market Share, 2020-2030
Figure 48. Turkey Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 49. Israel Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 50. Saudi Arabia Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 51. UAE Hypoactive Sexual Desire Disorder Medication Revenue, (US$, Mn), 2020-2030
Figure 52. Global Hypoactive Sexual Desire Disorder Medication Production Capacity (K Units), 2020-2030
Figure 53. The Percentage of Production Hypoactive Sexual Desire Disorder Medication by Region, 2023 VS 2030
Figure 54. Hypoactive Sexual Desire Disorder Medication Industry Value Chain
Figure 55. Marketing Channels
